TWD
ZVRA icon

True Wealth Design’s Zevra Therapeutics ZVRA Stock Holding History

True Wealth Design’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55K Hold
108
– – ﹤0.01% 1806
2026
Q1 		$1.01K Hold
108
– – ﹤0.01% 1801
2025
Q4 		$968 Buy
108
+42
+64% +$397 ﹤0.01% 1717
2025
Q3 		$628 Buy
+66
New +$662 ﹤0.01% 1935

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

True Wealth Design's ZVRA Position: Q2 2026 in Review

True Wealth Design held its Zevra Therapeutics (ZVRA) position steady in Q2 2026 at 108 shares worth $1.55K. The position accounts for ﹤0.01% of the portfolio, ranked #1806.

True Wealth Design first reported a position in ZVRA in Q3 2025 and has held it in 4 quarters since. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • True Wealth Design held 108 shares of Zevra Therapeutics worth $1.55K as of Q2 2026.
  • True Wealth Design left its Zevra Therapeutics share count unchanged in Q2 2026.
  • Zevra Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1806 holding.
  • True Wealth Design first reported a position in Zevra Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.